Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2017 · 10-Q
Revenue$2.33B$2.33B−5.2% vs Q1 2016 Net Income$18.79M$18.79M−22.2% vs Q1 2016 EPS Diluted$0.31$0.31−20.5% vs Q1 2016 Gross Profit$281,180,000−5.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow-$26,360,000N/M Free Cash Flowderived-$36,506,000N/M Margins · derivedGross margin12.1%−0.0 pt vs Q1 2016
Operating margin1.5%−0.3 pt vs Q1 2016
Net margin0.8%−0.2 pt vs Q1 2016
ended Mar 31, 2017 · filed May 3, 2017 · 33 d after period end